Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProgenaBiome has published pioneering studies linking specific gut microbes to anxiety disorders, demonstrated discrepancies in commercial probiotic labeling versus actual content, shown individualized differences in human microbiomes, investigated the impact of Ivermectin on the microbiome, and continues clinical collaborations around FMT for gastrointestinal diseases. Their work has received multiple presidential awards at major gastroenterology conferences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProgenaBiome.